Table 1.

The clinical characteristics of stroke patients treated with intravenous thrombolysis at the time of admission to the hospital, including the mRS scale.

Clinical Parameters		Favourable (N = 26) (mRS 0–2 pts)	Unfavourable (N = 96) (mRS 3–6 pts)	p-Value
Age	Median [Q1, Q3]	58.8 [51.3, 69.3]	68.3 [61.0, 77.3]	0.002
Gender (male)	n (%)	18 (69.2%)	54 (56.3%)	0.268
Current smoking	n (%)	10 (38.5%)	28 (29.2%)	0.474
SBP on admission	Median [Q1, Q3]	145.8 [131, 155]	159.9 [146, 171]	0.002
DBP on admission	Median [Q1, Q3]	80.0 [75.0, 90.0]	89.0 [79.8, 98.3]	0.0692
Hyperlipidaemia	n (%)	2 (7.7%)	11 (11.4%)	1
Hyperuricemia	n (%)	1 (3.8%)	5 (5.2%)	1
Impaired renal function	n (%)	0 (0%)	3 (3.1%)	1
Gout	n (%)	1 (3.8%)	5 (5.2%)	1
Diabetes Mellitus	n (%)	9 (34.6%)	41 (42.7%)	0.507
Arterial hypertension	n (%)	18 (69.2%)	85 (88.5%)	0.0289
Coronary heart disease	n (%)	1 (3.8%)	26 (27.1%)	0.014
Atrial fibrillation	n (%)	0 (0%)	15 (15.6%)	0.039
Statin therapy before stroke	n (%)	6 (23.1%)	30 (31.3%)	0.625
Statin therapy after stroke	n (%)	26 (100%)	88 (91.7%)	0.584
Anticoagulant therapy before the stroke	n (%)	0 (0%)	3 (3.1%)	1
Infection	n (%)	0 (0%)	20 (20.8%)	0.007
Antibiotic	n (%)	0 (0%)	20 (20.8%)	0.007
NIHSS on admission	Median [Q1, Q3]	3.00 [2.00, 3.75]	5.00 [4.00, 10.0]	<0.001
NIHSS on discharge	Median [Q1, Q3]	0 [0, 1.00]	2.00 [1.00, 5.00]	<0.001
mRS on admission	Median [Q1, Q3]	2.00 [2.00, 2.00]	4.00 [3.00, 5.00]	<0.001
mRS on discharge	Median [Q1, Q3]	0 [0, 0]	1.00 [1.00, 3.00]	<0.001
mRS after three months	Median [Q1, Q3]	0 [0, 0]	1 [0, 3.00]	<0.001
mRS after a year	Median [Q1, Q3]	0 [0, 0.250]	1.00 [0, 2.00]	0.003

Abbreviations: DBP—Diastolic Blood Pressure; SBP—Systolic Blood Pressure.